Literature DB >> 12783277

Four-year experience of use of the Cobas Amplicor system for rapid detection of Mycobacterium tuberculosis complex in respiratory and nonrespiratory specimens in Greece.

S Levidiotou1, G Vrioni, E Galanakis, E Gesouli, C Pappa, D Stefanou.   

Abstract

To evaluate the experience of a clinical microbiology laboratory with a DNA amplification assay for routine detection of Mycobacterium tuberculosis, the Cobas Amplicor Mycobacterium tuberculosis (MTB) polymerase chain reaction (PCR) assay (Roche Diagnostics Systems, USA) was performed on 7,722 respiratory and 1,451 nonrespiratory specimens collected from 3,321 patients. The results were compared with those of culture in conventional Lowenstein-Jensen medium, culture in the MB/BacT system (Organon Teknika, France), and clinical investigations. A total of 240 of the 254 respiratory specimens culture positive for Mycobacterium tuberculosis were also positive in the PCR assay. Of the 7,300 culture-negative specimens, 45 (0.6%) were positive in the PCR. After detailed interpretation, the overall sensitivity, specificity, and positive and negative predictive values of the PCR assay were 84.5, 99.8, 94.1, and 99.4%, respectively, for respiratory specimens. The PCR assay was more sensitive for smear-positive respiratory specimens (97.1%) than for smear-negative respiratory specimens (48.6%). Of the 18 culture-positive (smear-negative) nonrespiratory specimens, 9 were positive in the PCR. None of the 1,384 culture-negative nonrespiratory specimens were positive in the PCR. The inhibition rates detected by the internal control of the test were 2.2% for respiratory specimens and 3.4% for nonrespiratory specimens. After resolving the discrepancies, the overall sensitivity, specificity, and positive and negative predictive values of the PCR assay were 82.5, 99.8, 94.3, and 99.4%, respectively, when compared to the results of diagnostic culture. In conclusion, the use of the Cobas Amplicor MTB-PCR assay might enable clinical microbiology laboratories with considerable previous experience in molecular biology testing to perform PCR and confirm tuberculosis infection immediately, leading to improved patient management.

Entities:  

Mesh:

Year:  2003        PMID: 12783277     DOI: 10.1007/s10096-003-0931-5

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  22 in total

1.  Sputum digestion and decontamination with N-acetyl-L-cysteine-sodium hydroxide for culture of mycobacteria.

Authors:  G P KUBICA; W E DYE; M L COHN; G MIDDLEBROOK
Journal:  Am Rev Respir Dis       Date:  1963-05

2.  Evaluation of commercial DNA and rRNA amplification assays for assessment of treatment outcome in pulmonary tuberculosis patients.

Authors:  I Rajalahti; P Vuorinen; K Liippo; M M Nieminen; A Miettinen
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2001-10       Impact factor: 3.267

3.  Performance assessment of new multiplex probe assay for identification of mycobacteria.

Authors:  E Tortoli; A Nanetti; C Piersimoni; P Cichero; C Farina; G Mucignat; C Scarparo; L Bartolini; R Valentini; D Nista; G Gesu; C P Tosi; M Crovatto; G Brusarosco
Journal:  J Clin Microbiol       Date:  2001-03       Impact factor: 5.948

4.  Improved detection and differentiation of mycobacteria with combination of Mycobacterium Growth Indicator Tube and Roche COBAS AMPLICOR System in conjunction with Duplex PCR.

Authors:  E J Oh; Y J Park; C L Chang; B K Kim; S M Kim
Journal:  J Microbiol Methods       Date:  2001-07-30       Impact factor: 2.363

5.  Multicenter evaluation of two commercial amplification kits (Amplicor, Roche and LCx, Abbott) for direct detection of Mycobacterium tuberculosis in pulmonary and extrapulmonary specimens.

Authors:  E Tortoli; M Tronci; C P Tosi; C Galli; F Lavinia; S Natili; A Goglio
Journal:  Diagn Microbiol Infect Dis       Date:  1999-03       Impact factor: 2.803

6.  Comparative evaluation of two commercial amplification assays for direct detection of Mycobacterium tuberculosis complex in respiratory specimens.

Authors:  C Piersimoni; A Callegaro; D Nista; S Bornigia; F De Conti; G Santini; G De Sio
Journal:  J Clin Microbiol       Date:  1997-01       Impact factor: 5.948

7.  Evaluation of Gen-Probe Amplified Mycobacterium Tuberculosis Direct Test and Roche PCR-microwell plate hybridization method (AMPLICOR MYCOBACTERIUM) for direct detection of mycobacteria.

Authors:  S Ichiyama; Y Iinuma; Y Tawada; S Yamori; Y Hasegawa; K Shimokata; N Nakashima
Journal:  J Clin Microbiol       Date:  1996-01       Impact factor: 5.948

8.  Monitoring treatment of patients with pulmonary tuberculosis: can PCR be applied?

Authors:  V O Thomsen; A Kok-Jensen; M Buser; S Philippi-Schulz; H J Burkardt
Journal:  J Clin Microbiol       Date:  1999-11       Impact factor: 5.948

9.  Comparison of the Roche AMPLICOR MYCOBACTERIUM assay and Digene SHARP Signal System with in-house PCR and culture for detection of Mycobacterium tuberculosis in respiratory specimens.

Authors:  T S Huang; Y C Liu; H H Lin; W K Huang; D L Cheng
Journal:  J Clin Microbiol       Date:  1996-12       Impact factor: 5.948

10.  Direct detection of Mycobacterium tuberculosis complex in respiratory specimens by Gen-Probe Amplified Mycobacterium Tuberculosis Direct Test and Roche Amplicor Mycobacterium Tuberculosis Test.

Authors:  P Vuorinen; A Miettinen; R Vuento; O Hällström
Journal:  J Clin Microbiol       Date:  1995-07       Impact factor: 5.948

View more
  10 in total

1.  Is real-time PCR better than conventional PCR for Mycobacterium tuberculosis complex detection in clinical samples?

Authors:  Enrico Tortoli; Pasquale Urbano; Fiorella Marcelli; Tullia M Simonetti; Daniela M Cirillo
Journal:  J Clin Microbiol       Date:  2012-06-12       Impact factor: 5.948

2.  Comparison of five methods for extraction of Legionella pneumophila from respiratory specimens.

Authors:  Deborah Wilson; Belinda Yen-Lieberman; Udo Reischl; Ilka Warshawsky; Gary W Procop
Journal:  J Clin Microbiol       Date:  2004-12       Impact factor: 5.948

Review 3.  Molecular diagnostics in tuberculosis.

Authors:  V C C Cheng; W W Yew; K Y Yuen
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2005-11       Impact factor: 3.267

Review 4.  Current evidence on diagnostic accuracy of commercially based nucleic acid amplification tests for the diagnosis of pulmonary tuberculosis.

Authors:  S Greco; E Girardi; A Navarra; C Saltini
Journal:  Thorax       Date:  2006-05-31       Impact factor: 9.139

5.  Direct detection of Nocardia spp. in clinical samples by a rapid molecular method.

Authors:  Andrée Couble; Verónica Rodríguez-Nava; Michèle Pérouse de Montclos; Patrick Boiron; Frédéric Laurent
Journal:  J Clin Microbiol       Date:  2005-04       Impact factor: 5.948

6.  Rapid detection of the Mycobacterium tuberculosis complex by use of quenching probe PCR (geneCube).

Authors:  Yukio Hida; Kyoko Hisada; Akihiro Shimada; Masanori Yamashita; Hideki Kimura; Haruyoshi Yoshida; Hiromichi Iwasaki; Masayuki Iwano
Journal:  J Clin Microbiol       Date:  2012-08-29       Impact factor: 5.948

7.  Clinical evaluation of TRCRapid M.TB for detection of Mycobacterium tuberculosis complex in respiratory and nonrespiratory specimens.

Authors:  Haruka Tanaka; Haruka Hirose; Yuko Kato; Saori Kida; Eiji Miyajima
Journal:  J Clin Microbiol       Date:  2010-03-03       Impact factor: 5.948

8.  Direct detection of rifampin-resistant mycobacterium tuberculosis in respiratory specimens by PCR-DNA sequencing.

Authors:  W C Yam; C M Tam; C C Leung; H L Tong; K H Chan; E T Y Leung; K C Wong; W W Yew; W H Seto; K Y Yuen; P L Ho
Journal:  J Clin Microbiol       Date:  2004-10       Impact factor: 5.948

Review 9.  Molecular diagnostics in tuberculosis: basis and implications for therapy.

Authors:  Seetha V Balasingham; Tonje Davidsen; Irena Szpinda; Stephan A Frye; Tone Tønjum
Journal:  Mol Diagn Ther       Date:  2009       Impact factor: 4.074

10.  Commercial nucleic-acid amplification tests for diagnosis of pulmonary tuberculosis in respiratory specimens: meta-analysis and meta-regression.

Authors:  Daphne I Ling; Laura L Flores; Lee W Riley; Madhukar Pai
Journal:  PLoS One       Date:  2008-02-06       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.